The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders
The combination of obesity and type 2 diabetes is a serious health problem, which is projected to afflict 300 million people worldwide by 2020. Both clinical and translational laboratory studies have demonstrated that chronic inflammation is associated with obesity and obesity-related conditions suc...
Saved in:
Main Authors: | Elisa Benetti, Fausto Chiazza, Nimesh S. A. Patel, Massimo Collino |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2013/678627 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mediators of Interorgan Crosstalk in Metabolic Inflammation
by: Massimo Collino, et al.
Published: (2013-01-01) -
Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders
by: Keren Zhou, et al.
Published: (2016-01-01) -
NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics
by: Yuzhou Liu, et al.
Published: (2025-01-01) -
Metabolic Dysfunction in the Regulation of the NLRP3 Inflammasome Activation: A Potential Target for Diabetic Nephropathy
by: Wenli Zhao, et al.
Published: (2022-01-01) -
NLRP3 Inflammasome Activation Is Involved in Geniposide-Induced Hepatotoxicity
by: Yixuan Liu, et al.
Published: (2025-01-01)